Find Academic Supervisors

Pascal SyrenView profile

Researcher

• Cardiac Electrophysiology
• Histone Deacetylases
• Ventricular Arrhythmias
• +3 more

Dr. Pascal Syren is a **Researcher** and **Resident** at Heidelberg University Hospital (UKHD), affiliated with the **Department of Cardiology, Angiology, and Pulmonology** and the **Heidelberg Center for Cardiac Arrhythmias**. His academic role includes contributing to the **Group of Molecular and Translational Cardiac Electrophysiology**, focusing on epigenetic and molecular mechanisms underlying cardiac arrhythmias and heart failure. He holds a PhD from Heidelberg University (2021) on histone deacetylases' influence in cardiac electrophysiology. **Research Interests**: Cardiac electrophysiology, epigenetic regulation (HDACs), ventricular and atrial arrhythmias, echocardiography, and translational cardiology. His work spans basic science to clinical applications, emphasizing ion channel remodeling and therapeutic targets for heart rhythm disorders. **Awards**: Recipient of the **Ernst & Berta Grimmke Foundation Research Grant (2023–2024)** and **Otto-Hess Scholarship (2017–2018)** from the German Cardiac Society. His research bridges molecular mechanisms with clinical cardiology, with contributions to understanding HDAC2's role in action potential dynamics. **Publications**: Over 8 peer-reviewed articles (2016–2025) in journals like *Basic Research in Cardiology* and *Cells*, focusing on histone deacetylase pathways, atrial fibrillation, and ventricular arrhythmia models. Recent work explores neonatal cardiomyocyte electrophysiology and TREK-1 potassium channels in heart failure. **Affiliations**: Active member of the **German Cardiac Society (DGK)** and **European Society of Cardiology (ESC)**, contributing to interdisciplinary cardiac arrhythmia research at Heidelberg's medical faculty.

Jean-Philippe ThiranView profile

Professor

• Computational Imaging
• Medical Image Analysis
• Diffusion MRI
• +5 more

Prof. Jean-Philippe Thiran is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he serves as Director of the Signal Processing Laboratory (LTS5) and Director of the Institute of Electrical and Micro Engineering. He also maintains a part-time Associate Professor position with the Department of Radiology of the University Hospital Center (CHUV) and University of Lausanne (UNIL). Born in Namur, Belgium in 1970, he received his Electrical Engineering degree and PhD from the Université catholique de Louvain (UCL), Belgium, in 1993 and 1997 respectively. He joined EPFL in 1998 and has established himself as a leading researcher in computational imaging. His research focuses on computational imaging , with significant contributions to medical image analysis (particularly diffusion MRI, ultrasound imaging, and digital pathology) and computer vision . His recent work integrates advanced modeling, simulation, and machine learning techniques to extract microscopic tissue information from macroscopic MRI signals. This approach combines hyper-realistic synthetic tissue models, advanced Monte-Carlo simulations, and ML-based estimation techniques for brain microstructure analysis with potential applications to other tissues. Senior Member of IEEE Fellow of the European Association for Signal Processing (EURASIP) Prof. Thiran has authored or co-authored 1 book, 9 book chapters, 250 journal papers and over 270 peer-reviewed conference papers, and holds 12 international patents. He previously served as Co-Editor-in-Chief of the Signal Processing journal (2001-2005) and associate editor of IEEE Transactions on Image Processing. He has chaired major conferences including EUSIPCO 2008 and IEEE ICIP 2015. His laboratory at EPFL brings together interdisciplinary researchers to develop innovative imaging techniques that bridge macroscopic measurements and microscopic tissue properties, with significant potential for medical diagnostics and treatment planning applications.

Rebecca PrattView profile

Professor

• Anatomy
• Fascial System Research
• Histology
• +12 more

Dr. Rebecca Pratt is a tenured Professor in the Department of Foundational Medical Studies at Oakland University William Beaumont School of Medicine (OUWB), where she has been a faculty member since January 2018. She previously held professorial roles at Michigan State University College of Osteopathic Medicine (MSUCOM), where she taught anatomy, embryology, neuroanatomy, physiology, and histology, and served as Associate Professor and Director of Histology at the West Virginia School of Osteopathic Medicine. She also held appointments at Grand Valley State University and completed postdoctoral training at Purdue University. Ph.D., Cell Biology and Oncology, Purdue University B.S., Zoology and Botany/Plant Pathology, Michigan State University Dr. Pratt's research focuses on the fascial system and its role in whole-body health, including fascial continuity, muscle attachment, somatic pain transmission, and biochemical communication. She integrates radiology into anatomy education and advocates for evidence-based medical curricula. Her work bridges clinical anatomy, histology, embryology, and physiology with modern educational practices. Her recent publications reflect a strong emphasis on fascial anatomy, medical education innovation, and the integration of imaging in teaching. Themes include plastination, generational learning trends, and fascia’s role in women's health and athletic performance, published in journals like Clinical Anatomy and Anatomical Sciences Education , as well as in Women and Men’s Health and NIKE magazines. Scientific awards and honors include: Basmajian Award (American Association of Anatomy) Keith and Marion Moore Award (AAA) Five consecutive Golden Apple Teaching Awards at MSUCOM Golden Apple Award at OUWB Dr. Pratt has served in major leadership roles, including President of the International Fascia Research Society, Board Member of the American Association of Anatomy (AAA) and the American Association of Clinical Anatomy (AACA), and Chair of multiple AAA committees. She is a Visiting Anatomy Professor at Weill Cornell and St. George’s University School of Medicine, and faculty advisor for the Docapellas at OUWB. She has been an invited speaker internationally and contributed to high-impact projects like the BodyWorlds Fascial Net Plastination Project. She actively serves on OUWB’s Admissions and Student Promotion and Retention Committees. Dr. Pratt leads and organizes major international initiatives, including the Women's Clinical Health Summit in Rio de Janeiro (2024) and the Fascia Research Congress in New Orleans (2025), fostering global collaboration in fascial science. Her lab and research team focus on fascial anatomy and medical education, working closely with institutions in Italy (University of Padova) and Germany (BodyWorlds project).

Waldemar KolanusView profile

Professor

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +4 more

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

• Inverse problems and reconstruction
• Neuroimaging
• Quantitative MRI
• +1 more

Daan Christiaens is a tenure track lecturer at KU Leuven's Faculty of Medicine and Faculty of Engineering Sciences. He is affiliated with the Department of Electrical Engineering (ESAT) and Department of Imaging & Pathology, serving as a member of the Medical Imaging Division and the KU Leuven Brain Institute (LBI). His academic responsibilities include membership in the Faculty Councils of Engineering Sciences and Medicine. His research focuses on: Inverse problems in medical imaging reconstruction Neuroimaging techniques for brain analysis Advanced quantitative MRI methodologies Diffusion-weighted imaging for microstructural assessment Dr. Christiaens' recent publications (2023-2025) demonstrate a consistent focus on diffusion MRI innovations, including novel reconstruction algorithms, neonatal brain development mapping, and clinical applications for neurodegenerative disorders. Key technical themes include motion correction, multi-shell modeling, and AI-enhanced image processing, while clinical applications span Alzheimer's disease, cerebral palsy, and autism research. He leads significant research projects including: MRI reconstruction with dynamic field monitoring (2024-2028) Compressed sensing for microstructure imaging (2022-2026) Neonatal diffusion MRI network connectivity analysis (2024-2028) As a core developer of the MRtrix3 software framework for medical image processing, he contributes to essential tools in neuroimaging research.

• Sports Medicine
• Physiology
• Sports Injury
• +4 more

Michael Kjær is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, Faculty of Health and Medical Sciences. He specializes in Internal Medicine: Rheumatology and leads research groups focused on exercise physiology, sports injuries, and aging. His work addresses the impact of physical activity on the human organism, with particular emphasis on tissue damage and repair mechanisms. Dr. Kjær's primary research interests center around sports medicine, physiology, and exercise science. His work investigates tendon pathology, muscle physiology, sports injuries, and the effects of exercise on aging populations. He has made significant contributions to understanding sports-related injuries, particularly tendon overuse conditions, and the physiological responses to physical activity across different age groups. His recent publications (2025) demonstrate a strong focus on tendon research, sports injury treatment dilemmas, effects of anabolic steroid abuse, muscle physiology, and bone health in athletes and older adults. The research spans from basic science investigations of cellular mechanisms to clinical studies addressing practical sports medicine challenges. His work shows particular strength in connecting molecular and tissue-level changes with clinical outcomes in sports medicine. With 415 research outputs including 369 journal articles, 15 book chapters, and 15 reviews, Dr. Kjær maintains an active research program with substantial impact. His work has been referenced in Wikipedia pages, cited by Bluesky users, and picked up by news outlets, demonstrating its relevance to both academic and public discourse. Dr. Kjær leads multiple research groups within the Center for Healthy Aging Damage and Repair at the Department of Clinical Medicine. His laboratory work focuses on tissue response to injury and exercise, particularly examining tendon and muscle physiology using both in vivo and in vitro approaches. His research bridges basic science with clinical applications in sports medicine and rehabilitation.

• Medical Image Analysis
• Machine Learning in Medical Imaging
• Neuroimaging
• +5 more

Lawrence Staib is Professor of Radiology and Biomedical Imaging, Biomedical Engineering, and Electrical Engineering at Yale University. He serves as Director of Undergraduate Studies in Biomedical Engineering and is a member of Yale's Bioimaging Sciences division, Image Processing & Analysis Group, Yale Biomedical Imaging Institute, and Yale-BI Biomedical Data Science Fellowship program. Dr. Staib earned his A.B. in Physics from Cornell University (1982), followed by a Ph.D. in Engineering and Applied Science from Yale University (1990), and completed a postdoctoral fellowship at Yale School of Medicine (1991). His research focuses on developing advanced medical image analysis methods using machine learning and model-based approaches. Key research areas include neuroimaging applications for autism spectrum disorder classification, cardiac imaging analysis for strain and motion assessment, prostate cancer diagnosis and risk mapping, and innovative techniques for medical image segmentation with limited labeled data. Dr. Staib's work emphasizes uncertainty estimation in deep learning models, multi-modal image registration, and domain adaptation techniques to improve clinical decision support systems. His recent publications demonstrate a strong trend toward developing interpretable AI models for clinical applications, with particular emphasis on fMRI analysis for neurological conditions, cardiac motion analysis, and prostate cancer diagnosis. His work frequently addresses the challenge of limited labeled data in medical imaging through innovative self-supervised, semi-supervised, and few-shot learning approaches. Fellow of the American Institute for Medical and Biological Engineering (AIMBE) (2015) Distinguished Investigator Award from the Academy for Radiology & Biomedical Imaging Research (2017) MICCAI Fellow (2022) Medical Image Analysis Second Best MICCAI Paper Award (2005) ASNR Cum Laude Scientific Exhibit Award (2003) Dr. Staib serves on the editorial board of Medical Image Analysis and as Associate Editor of IEEE Transactions on Biomedical Engineering. His research is supported by NIH grants including the Autism Center of Excellence program. He leads the Image Processing & Analysis Group within Yale's Bioimaging Sciences division, collaborating extensively with James Duncan, John Onofrey, Xenophon Papademetris, and other Yale researchers on applications spanning neuroimaging, cardiology, and oncology. Current projects focus on developing robust AI models for clinical decision support with emphasis on uncertainty quantification and interpretability.

Behnaam AazhangView profile

Professor

• Signal and Data Processing
• Information Theory
• Neuroengineering
• +4 more

Behnaam Aazhang is the J.S. Abercrombie Professor of Electrical and Computer Engineering at Rice University and Director of the Rice Neuroengineering Initiative (NEI). He holds a B.S., M.S., and Ph.D. from the University of Illinois at Urbana-Champaign. His roles include leading the multi-university Rice Neuroengineering Initiative and directing the Center for Neuroengineering. He has held an Academy of Finland Distinguished Visiting Professorship (FiDiPro) at the University of Oulu (2006-2014) and received an Honorary Doctorate from the University of Oulu in 2017. Education: Ph.D. in Electrical Engineering, University of Illinois at Urbana-Champaign (1986) M.S. in Electrical Engineering, University of Illinois at Urbana-Champaign (1983) B.S. in Electrical Engineering, University of Illinois at Urbana-Champaign (1981) Research Interests: Dr. Aazhang’s work focuses on signal/data processing, information theory, and neuroengineering applications. Key areas include: Neuronal circuit connectivity and learning impacts Real-time closed-loop neuromodulation for neurological disorders (epilepsy, Parkinson’s, depression) Patient-specific cardiac pacing systems Cybersecurity in cloud computing Awards & Honors: 2022 Rice Outstanding Doctoral Thesis Advisor Award 2019 SIGMOBILE Test of Time Award 2017 Honorary Doctorate (University of Oulu) 2013 IEEE Communication Society Advances in Communication Award AAAS and IEEE Fellowships (2012 and 1999) Grants & Advising: His research is supported by multi-university collaborations and grants. He has advised numerous graduate students in electrical engineering and neuroengineering, though specific names are not listed here. Labs & Teams: Leads the Aazhang Lab and the Rice Neuroengineering Initiative, focusing on translational technologies for neurological and cardiac disorders, including non-invasive neuromodulation and cloud security systems.

Istvan ModyView profile

Professor

• Neuroscience
• Neurology
• Pharmacology
• +12 more

Istvan Mody is a Professor at the University of California, Los Angeles (UCLA) with appointments in the Department of Neurology and Department of Physiology . His research focuses on synaptic signaling in health and disease, including mechanisms of GABAergic transmission, calcium homeostasis, and their roles in neurological disorders such as epilepsy, Alzheimer's disease, Huntington's disease, stress, alcoholism, and postpartum depression. He utilizes advanced techniques like patch-clamp electrophysiology, neuroanatomical and immunohistochemical methods, and molecular biology in animal models and human brain tissue . Research Interests: Dr. Mody investigates the physiology, pharmacology, and pathology of synaptic transmission and extrasynaptic receptor activation , with a particular emphasis on GABA(A) receptors and their subunit-specific modulation. His work explores how disruptions in excitation-inhibition balance contribute to neurological diseases, including mechanisms of tonic inhibition , calcium signaling , and neurosteroid interactions . He also studies the effects of chronic stress and hormonal fluctuations on neural excitability and behavior. Publications Trends: Recent studies highlight his work on gamma oscillations in Alzheimer's models, microglial dynamics , and rehabilitation strategies for stroke. His lab develops optical tools like dqGEVI for neuronal activity monitoring and investigates human brain organoids to model network dysfunction in epilepsy and intellectual disability. Laboratory Location: 635 Charles Young Dr S, Los Angeles, CA 90095, United States.

• Skeletal Muscle Growth
• Ribosome Biogenesis
• Exercise Physiology
• +4 more

Gustavo Nader, Ph.D., is a Professor of Kinesiology at The Pennsylvania State University's College of Health and Human Development, where he holds the Dorothy Foehr Huck and J. Loyd Huck Endowed Chair in Molecular, Cellular and Integrative Physiology. His research laboratory at 101 Noll Lab focuses on molecular mechanisms of skeletal muscle adaptation, employing human, animal, and cellular models to investigate ribosome biogenesis, transcriptional regulation, and muscle growth control in contexts ranging from exercise hypertrophy to cancer cachexia. Dr. Nader's research examines fundamental processes including: Ribosome biogenesis and its role in muscle growth regulation Epigenetic control of RNA Polymerase I activity Molecular pathways in mechanical overload-induced hypertrophy Tumor-induced muscle wasting mechanisms Biomimicry approaches inspired by hibernator physiology His work spans exercise physiology, cancer biology, and environmental stress responses. Analysis of his 15 most recent publications (2015-2025) reveals predominant themes in muscle hypertrophy mechanisms, cancer cachexia pathophysiology, ribosomal function analysis, and environmental stress impacts on muscle. His work consistently integrates molecular techniques with physiological models across species. Notable scientific recognitions include: Dorothy Foehr Huck and J. Loyd Huck Chair appointment (2024) Huck Institutes Leadership Fellowship (2025-2026) Dr. Nader leads an active research team investigating muscle plasticity, with current projects funded through the Huck Institutes of the Life Sciences. He collaborates extensively through Penn State's Integrative and Biomedical Physiology graduate program and Center for Cellular Dynamics.

• Drug Delivery
• Pharmaceutics
• Nanomedicine
• +5 more

Caitriona M. O'Driscoll is Professor and Chair of Pharmaceutics at University College Cork's School of Pharmacy, Ireland. With over four decades of academic experience, she previously served as Head of the School of Pharmacy at UCC from 2003-2009 and 2010-2013. Her established drug delivery research team spans from pre-formulation through to production and manufacture of prototype delivery systems suitable for clinical trial, with strong industry links underpinning many research projects. Her research interests focus on translational drug delivery with emphasis on 'problem' drugs including poorly water soluble compounds and biopharmaceuticals like peptide/protein drugs, plasma DNA and siRNA. She develops nano-sized delivery constructs that are robust enough to survive processing, stable on storage, and achieve cell/site specific delivery in vivo. Greater than 40% of new chemical entities are poorly water soluble Biopharmaceuticals now approach 50% of all new drugs in development Major barrier is design of efficient delivery systems Special focus on oral drug delivery despite challenges Analysis of her recent publications reveals a strong emphasis on targeted nanodelivery systems for cancer therapy, particularly prostate and colorectal cancer, as well as neurodegenerative diseases like Huntington's. Her work demonstrates expertise in cyclodextrin-based nanoparticles, siRNA delivery, and disease-specific formulations that account for conditions like Crohn's disease that affect drug delivery. Scientific awards include: 'Person of the Year award' by Parenteral Drug Association (Ireland Chapter) in 2013 'Award for Professional Excellence' by Helix Health in 2007/2008 'Award for Pharmacist of the Year' by Helix Health in 2007/2008 With €10.5M in career research income and 25 PhDs graduated, Professor O'Driscoll's work has attracted funding from diverse sources including Science Foundation Ireland, Enterprise Ireland, and industry partners. Her research group maintains strong links with Pharmaceutical Chemistry and Process & Chemical Engineering at UCC, creating a unique strength for drug development research from design through to clinical trial. She has served as external examiner for multiple universities and as PhD thesis examiner at institutions worldwide. Her research team operates within UCC's drug delivery group, which has established expertise spanning from pre-formulation through to production and manufacture of prototype delivery systems. The group maintains strong industry connections and offers various PhD positions, focusing particularly on translational research with product-driven applications.

Martin JastrochView profile

Professor

• Energy Metabolism
• Obesity Research
• Adipose Tissue Biology
• +4 more

Martin Jastroch is a Professor at Stockholm University's Department of Molecular Biosciences, The Wenner-Gren Institute. His research focuses on the physiology and molecular mechanisms of energy metabolism from organism to molecule level. His primary research interests include: Energy metabolism physiology and molecular mechanisms Obesity and metabolic aspects Adipose tissue biology Mitochondrial mechanisms Thermogenesis and brown fat function Metabolic regulation in health and disease Professor Jastroch's research spans multiple disciplines, connecting molecular mechanisms with whole-organism physiology. His work on mitochondrial bioenergetics and thermogenesis has contributed significantly to understanding how energy metabolism is regulated across different biological scales. Recent publications show a growing interest in the evolutionary aspects of thermogenesis and the role of brown adipose tissue in metabolic diseases, with particular focus on UCP1 function, mitochondrial adaptations, and metabolic reprogramming in disease states. His scientific contributions include important findings on: UCP1 (Uncoupling Protein 1) function and regulation Mitochondrial bioenergetics in different tissue types Evolutionary aspects of mammalian thermogenesis Metabolic regulation in obesity and related disorders Links between mitochondrial dysfunction and neurodegenerative diseases Professor Jastroch leads 'Group Jastroch' at Stockholm University, where his team investigates the complex interplay between cellular energy metabolism and whole-body physiology, with implications for understanding and treating metabolic disorders.

• Apoptosis
• Biochemistry
• Breast Neoplasms
• +5 more

Professor Faye Rogers serves as Professor of Therapeutic Radiology at Yale University School of Medicine, holding multiple leadership positions including Associate Cancer Center Director for YCC Collaborative Excellence, Vice Chair for Collaborative Excellence in Therapeutic Radiology, Associate Director of the Yale MD-PhD Program, and Director of the Yale BioMed Amgen Scholars Program. Her work bridges radiation oncology, DNA repair mechanisms, and cancer therapeutics within Yale's comprehensive cancer research ecosystem. PhD from University of Maryland at Baltimore (1998) Postdoctoral Fellow at Yale School of Medicine Dr. Rogers' research focuses on the intersection of DNA repair mechanisms and cancer therapeutics, with particular expertise in triplex DNA structures, genomic instability, and targeted cancer therapies. Her work explores how DNA damage responses can be leveraged for therapeutic benefit, especially in breast neoplasms and other malignancies. Through her leadership in the DNA Damage and Genome Integrity program, she investigates novel approaches to disrupt cancer cell survival mechanisms while sparing healthy tissue. Her research has significant implications for radiation oncology, particularly in developing more precise and effective radiation-based treatments. Analysis of Dr. Rogers' publication record reveals a consistent trajectory in DNA repair mechanisms and cancer therapeutics, with increasing focus on translational applications. Her work demonstrates expertise in triplex DNA structures, RAD51 inhibition, and synthetic lethality approaches. Recent publications show a shift toward more clinically applicable research, particularly in targeting DNA repair pathways in specific cancer subtypes like IDH1-mutant cancers and PTEN-deficient glioblastomas. Her collaborative work with Peter Glazer and others demonstrates strong interdisciplinary connections between radiation oncology, molecular biology, and drug development. Leadership in Diversity, Equity & Inclusion Award (Yale School of Medicine, 2022) Translational Science Research Prize (Yale Cancer Center, 2022) Kingsley Fellowship in Medical Research Carl Storm Underrepresented Minority Fellowship NCI Research Supplement to Promote Diversity in Health-Related Research As Associate Director of the Yale MD-PhD Program and Director of the Yale BioMed Amgen Scholars Program, Dr. Rogers plays a pivotal role in mentoring the next generation of physician-scientists and supporting underrepresented minorities in biomedical research. Her leadership in collaborative excellence initiatives demonstrates commitment to fostering interdisciplinary research teams across Yale's scientific ecosystem. Through the YCC Collaborative Excellence program, she has secured significant funding for innovative cancer research that bridges basic science and clinical applications, particularly in the areas of DNA repair targeting and radiation oncology. Dr. Rogers leads research within Yale's Therapeutic Radiology department, with strong connections to the Radiobiology program and the Yale Cancer Center. Her work is integrated with the Program in Translational Biomedicine and the Yale Combined Program in the Biological and Biomedical Sciences. Through the BioMed Amgen Scholars Program, she provides critical research opportunities for undergraduate students, particularly those from underrepresented backgrounds, fostering talent in DNA repair research and cancer therapeutics.

James Ashton-MillerView profile

Professor

• Biomechanics
• ACL injury
• Sports injury
• +15 more

Dr. James Ashton-Miller is a prominent faculty member in the Department of Mechanical Engineering at the University of Michigan, where he directs the Biomechanics Research Laboratory. He serves as a Center Member of the University of Michigan Injury Prevention Center and maintains affiliations with the Institute of Gerontology. His interdisciplinary work bridges engineering principles with medical applications, focusing on injury prevention across sports medicine, obstetrics, and geriatrics. Dr. Ashton-Miller's educational background includes: PhD from the University of Oslo, Oslo, Norway (1978-1983) MSME from M.I.T., Cambridge, MA, U.S.A (1972-1974) B.SC. (Hons) from the University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, England (1967-1972) His research focuses on the biomechanics of injury prevention across multiple critical domains. In sports medicine, he has demonstrated that some ACL injuries are overuse injuries resulting from too many sub-maximal loading cycles that prevent healing of collagen damage. In women's health, his work on childbirth injuries addresses conditions that affect more women than breast cancer. His research on fall-related injuries in older adults reveals the dual threat of physical and cognitive factors. He also investigates sciatica, disc degeneration, and develops new medical devices for screening, diagnosis and treatment. Dr. Ashton-Miller's recent publications show a strong trend toward developing practical clinical applications from fundamental biomechanical research, with emphasis on advanced imaging methods, wearable sensors, and computational modeling for pelvic floor function assessment. His work consistently aims to translate engineering insights into clinical solutions for injury prevention. His research insights have earned him numerous national and international research awards, though specific awards aren't detailed in the available information. His work involves close collaboration with clinicians and surgeons who meet weekly to discuss progress and next steps. Dr. Ashton-Miller is deeply committed to mentoring, working with NIH K-series fellows along with 1-2 post-doctoral fellows, 3-5 PhD students, 2-4 M.S. students, 4-5 undergraduate students, and 2-4 young clinicians. His research is generously supported by the National Institutes of Health, National Science Foundation, National Basketball Association, Fortune 500 companies, and startup companies including Procter & Gamble and Hologic, Inc. He directs the Biomechanics Research Laboratory and co-leads the Pelvic Floor Research Group, where his teams develop new medical devices to improve screening, diagnosis, and treatment of various biomechanical conditions. These laboratories maintain strong clinical connections, ensuring research remains grounded in real-world medical challenges.

Olga DvorkinaView profile

Associate Professor

• Rheumatology
• Autoimmune Diseases
• Clinical Trials
• +3 more

Olga Dvorkina is an Associate Professor of Medicine in the Rheumatology Division at SUNY Downstate Health Sciences University. She specializes in systemic lupus erythematosus (SLE) research and clinical trials, focusing on disease activity, nephritis, and therapeutic interventions. Education : MD from Kaunas Medical Institute (1984) Training : Fellowship in Rheumatology (SUNY Downstate, 1997-1999), Residency in Internal Medicine (St. John's Episcopal Hospital, 1994-1997), Internship (Leningrad City Hospital #38, 1984-1986) Her research interests include clinical trials for SLE therapies, such as abatacept and belimumab, and investigating associations between lupus and comorbidities like atherosclerosis, malignancies, and neuropsychiatric manifestations. She contributes to the development of lupus classification criteria and flare assessment tools. Her recent publications and abstracts focus on SLE treatment safety, corticosteroid use, infections, and multi-center registry analyses. She collaborates with pharmaceutical companies (Ocean Blue, GSK, Aurinia, Takeda) and national consortia, including the Lupus Clinical Trials Consortium and Systemic Lupus International Collaborating Clinics. Notable projects include Phase 3 trials for belimumab and voclosporin in lupus nephritis. She mentors Rheumatology fellows and participates in educational initiatives through textbook authorship and clinical research training.